Skip to main content
Erschienen in: Journal of Artificial Organs 2/2013

01.06.2013 | Original Article

Activation of platelets upon contact with a vitamin E-coated/non-coated surface

verfasst von: Hiroshi Tsukao, Kenichi Kokubo, Haruko Takahashi, Mina Nagasato, Takanori Endo, Naoto Iizuka, Toshihiro Shinbo, Minoru Hirose, Hirosuke Kobayashi

Erschienen in: Journal of Artificial Organs | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to determine the effects of a vitamin E-coated surface on platelet activation, focusing on the interactions among the vitamin E-coated surface, platelets and leukocytes. Platelet-rich plasma (PRP) or PRP containing leukocytes (LPRP) was used. No difference was observed in platelet activation between PRP and LPRP for a vitamin E-coated membrane, meaning that platelet activation triggered by leukocytes was suppressed in plasma coming in contact with a vitamin E-coated membrane, while the membrane itself directly induced platelet activation. The antioxidant capacity of the vitamin E-coated membrane in contact with PRP or LPRP was partially reduced, but sufficient residual capacity remained. The in vitro experiments using an oxidized vitamin E-coated surface revealed that P-selectin expression and superoxide anion production in the platelets and platelet adhesion were induced by contact with the oxidized vitamin E-coated surface. We conclude that contact with a vitamin E-coated surface reduces platelet activation mediated by superoxide anions, probably by reducing superoxide anions, but during the process of the reduction, the vitamin E-coated surface itself becomes oxidized, which again causes platelet activation. The beneficial effects of a vitamin E-coated dialyzer in respect of platelet activation were counteracted by the formation of oxidized vitamin E.
Literatur
1.
Zurück zum Zitat Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290:697–701.PubMedCrossRef Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974;290:697–701.PubMedCrossRef
2.
Zurück zum Zitat O’Hare AM, Hsu CY, Bacchetti P, Johansen KL. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol. 2002;13:497–503.PubMed O’Hare AM, Hsu CY, Bacchetti P, Johansen KL. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol. 2002;13:497–503.PubMed
3.
Zurück zum Zitat Campean V, Neureiter D, Varga I, Runk F, Reiman A, Garlichs C, Achenbach S, Nonnast-Daniel B, Amann K. Atherosclerosis and vascular calcification in chronic renal failure. Kidney Blood Press Res. 2005;28:280–9.PubMedCrossRef Campean V, Neureiter D, Varga I, Runk F, Reiman A, Garlichs C, Achenbach S, Nonnast-Daniel B, Amann K. Atherosclerosis and vascular calcification in chronic renal failure. Kidney Blood Press Res. 2005;28:280–9.PubMedCrossRef
4.
Zurück zum Zitat Lam JY, Latour JG, Lesperance J, Waters D. Platelet aggregation, coronary artery disease progression and future coronary events. Am J Cardiol. 1994;73:333–8.PubMedCrossRef Lam JY, Latour JG, Lesperance J, Waters D. Platelet aggregation, coronary artery disease progression and future coronary events. Am J Cardiol. 1994;73:333–8.PubMedCrossRef
5.
Zurück zum Zitat Daub K, Lindemann S, Langer H, Seizer P, Stellos K, Siegel-Axel D, Gawaz M. The evil in atherosclerosis: adherent platelets induce foam cell formation. Semin Thromb Hemost. 2007;33:173–8.PubMedCrossRef Daub K, Lindemann S, Langer H, Seizer P, Stellos K, Siegel-Axel D, Gawaz M. The evil in atherosclerosis: adherent platelets induce foam cell formation. Semin Thromb Hemost. 2007;33:173–8.PubMedCrossRef
6.
Zurück zum Zitat Sanaka T, Higuchi C, Shinobe T, Nishimura H, Omata M, Nihei H, Sugino N. Lipid peroxidation as an indicator of biocompatibility in haemodialysis. Nephrol Dial Transplant. 1995;10(Suppl 3):34–8.PubMedCrossRef Sanaka T, Higuchi C, Shinobe T, Nishimura H, Omata M, Nihei H, Sugino N. Lipid peroxidation as an indicator of biocompatibility in haemodialysis. Nephrol Dial Transplant. 1995;10(Suppl 3):34–8.PubMedCrossRef
7.
Zurück zum Zitat Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–13.PubMedCrossRef Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–13.PubMedCrossRef
9.
Zurück zum Zitat Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull. 1993;49:566–76.PubMed Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull. 1993;49:566–76.PubMed
10.
Zurück zum Zitat Schmidt K, Graier WF, Kostner GM, Mayer B, Kukovetz WR. Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein. Biochem Biophys Res Commun. 1990;172:614–9.PubMedCrossRef Schmidt K, Graier WF, Kostner GM, Mayer B, Kukovetz WR. Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein. Biochem Biophys Res Commun. 1990;172:614–9.PubMedCrossRef
11.
Zurück zum Zitat Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254–7.PubMedCrossRef Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254–7.PubMedCrossRef
12.
Zurück zum Zitat Leake DS. Effects of mildly oxidized low-density lipoprotein on endothelial cell function. Curr Opin Lipidol. 1991;2:306–10.CrossRef Leake DS. Effects of mildly oxidized low-density lipoprotein on endothelial cell function. Curr Opin Lipidol. 1991;2:306–10.CrossRef
13.
Zurück zum Zitat Orekhov AN. Lipoprotein immune complexes and their role in atherogenesis. Curr Opin Lipidol. 1991;2:329–33.CrossRef Orekhov AN. Lipoprotein immune complexes and their role in atherogenesis. Curr Opin Lipidol. 1991;2:329–33.CrossRef
14.
Zurück zum Zitat Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA. 1987;84:2995–8.PubMedCrossRef Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA. 1987;84:2995–8.PubMedCrossRef
15.
Zurück zum Zitat Aggarwal A, Kabbani SS, Rimmer JM, Gennari FJ, Taatjes DJ, Sobel BE, Schneider DJ. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk. Am J Kidney Dis. 2002;40:315–22.PubMedCrossRef Aggarwal A, Kabbani SS, Rimmer JM, Gennari FJ, Taatjes DJ, Sobel BE, Schneider DJ. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk. Am J Kidney Dis. 2002;40:315–22.PubMedCrossRef
16.
Zurück zum Zitat Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613–7.PubMedCrossRef Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613–7.PubMedCrossRef
17.
Zurück zum Zitat Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990;322:1549–54.PubMedCrossRef Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990;322:1549–54.PubMedCrossRef
18.
Zurück zum Zitat Pascoe GA, Olafsdottir K, Reed DJ. Vitamin E protection against chemical-induced cell injury. I. Maintenance of cellular protein thiols as a cytoprotective mechanism. Arch Biochem Biophys. 1987;256:150–8.PubMedCrossRef Pascoe GA, Olafsdottir K, Reed DJ. Vitamin E protection against chemical-induced cell injury. I. Maintenance of cellular protein thiols as a cytoprotective mechanism. Arch Biochem Biophys. 1987;256:150–8.PubMedCrossRef
19.
Zurück zum Zitat Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase c-dependent mechanism. Circulation. 1996;94:2434–40.PubMedCrossRef Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase c-dependent mechanism. Circulation. 1996;94:2434–40.PubMedCrossRef
20.
Zurück zum Zitat Keaney JF, Jr., Simon DI, Freedman JE. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J. 1999;13:965–75. Keaney JF, Jr., Simon DI, Freedman JE. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J. 1999;13:965–75.
21.
Zurück zum Zitat Azzi A, Breyer I, Feher M, Pastori M, Ricciarelli R, Spycher S, Staffieri M, Stocker A, Zimmer S, Zingg JM. Specific cellular responses to alpha-tocopherol. J Nutr. 2000;130:1649–52.PubMed Azzi A, Breyer I, Feher M, Pastori M, Ricciarelli R, Spycher S, Staffieri M, Stocker A, Zimmer S, Zingg JM. Specific cellular responses to alpha-tocopherol. J Nutr. 2000;130:1649–52.PubMed
22.
Zurück zum Zitat Freedman JE, Keaney JF Jr. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr. 2001;131:374S–7S.PubMed Freedman JE, Keaney JF Jr. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr. 2001;131:374S–7S.PubMed
23.
Zurück zum Zitat Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr. 2003;77:700–6.PubMed Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr. 2003;77:700–6.PubMed
24.
Zurück zum Zitat Sasaki M. Development of vitamin E-modified polysulfone membrane dialyzers. J Artif Organs. 2006;9:50–60.PubMedCrossRef Sasaki M. Development of vitamin E-modified polysulfone membrane dialyzers. J Artif Organs. 2006;9:50–60.PubMedCrossRef
25.
Zurück zum Zitat Calo LA, Naso A, Pagnin E, Davis PA, Castoro M, Corradin R, Riegler P, Cascone C, Huber W, Piccoli A. Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis—a molecular biological approach. Clin Nephrol. 2004;62:355–61.PubMed Calo LA, Naso A, Pagnin E, Davis PA, Castoro M, Corradin R, Riegler P, Cascone C, Huber W, Piccoli A. Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis—a molecular biological approach. Clin Nephrol. 2004;62:355–61.PubMed
26.
Zurück zum Zitat Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant. 2005;20:2775–82.PubMedCrossRef Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant. 2005;20:2775–82.PubMedCrossRef
27.
Zurück zum Zitat Clermont G, Lecour S, Cabanne JF, Motte G, Guilland JC, Chevet D, Rochette L. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 2001;31:233–41.PubMedCrossRef Clermont G, Lecour S, Cabanne JF, Motte G, Guilland JC, Chevet D, Rochette L. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 2001;31:233–41.PubMedCrossRef
28.
Zurück zum Zitat Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, Makino H. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int. 2001;59:1943–50.PubMedCrossRef Satoh M, Yamasaki Y, Nagake Y, Kasahara J, Hashimoto M, Nakanishi N, Makino H. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int. 2001;59:1943–50.PubMedCrossRef
29.
Zurück zum Zitat Sosa MA, Balk EM, Lau J, Liangos O, Balakrishnan VS, Madias NE, Pereira BJ, Jaber BL. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21:2825–33.PubMedCrossRef Sosa MA, Balk EM, Lau J, Liangos O, Balakrishnan VS, Madias NE, Pereira BJ, Jaber BL. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21:2825–33.PubMedCrossRef
30.
Zurück zum Zitat Bazzoni G, Dejana E, Del Maschio A. Platelet–neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 1991;76:491–9.PubMed Bazzoni G, Dejana E, Del Maschio A. Platelet–neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 1991;76:491–9.PubMed
31.
Zurück zum Zitat Li N, Hu H, Lindqvist M, Wikstrom-Jonsson E, Goodall AH, Hjemdahl P. Platelet–leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol. 2000;20:2702–8.PubMedCrossRef Li N, Hu H, Lindqvist M, Wikstrom-Jonsson E, Goodall AH, Hjemdahl P. Platelet–leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol. 2000;20:2702–8.PubMedCrossRef
32.
Zurück zum Zitat Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol. 1993;151:3267–73.PubMed Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol. 1993;151:3267–73.PubMed
33.
Zurück zum Zitat Nagata K, Tsuji T, Hanai N, Irimura T. Role of O-linked carbohydrate chains on leukocyte cell membranes in platelet-induced leukocyte activation. J Biol Chem. 1994;269:23290–5.PubMed Nagata K, Tsuji T, Hanai N, Irimura T. Role of O-linked carbohydrate chains on leukocyte cell membranes in platelet-induced leukocyte activation. J Biol Chem. 1994;269:23290–5.PubMed
34.
Zurück zum Zitat Tsuji T, Nagata K, Koike J, Todoroki N, Irimura T. Induction of superoxide anion production from monocytes an neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J Leukoc Biol. 1994;56:583–7.PubMed Tsuji T, Nagata K, Koike J, Todoroki N, Irimura T. Induction of superoxide anion production from monocytes an neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J Leukoc Biol. 1994;56:583–7.PubMed
35.
Zurück zum Zitat Bath PM, Hassall DG, Gladwin AM, Palmer RM, Martin JF. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11:254–60.PubMedCrossRef Bath PM, Hassall DG, Gladwin AM, Palmer RM, Martin JF. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 1991;11:254–60.PubMedCrossRef
36.
Zurück zum Zitat Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science. 1990;249:414–7.PubMedCrossRef Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science. 1990;249:414–7.PubMedCrossRef
37.
Zurück zum Zitat Salvemini D, de Nucci G, Sneddon JM, Vane JR. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol. 1989;97:1145–50.PubMedCrossRef Salvemini D, de Nucci G, Sneddon JM, Vane JR. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol. 1989;97:1145–50.PubMedCrossRef
38.
Zurück zum Zitat Salvemini D, de Nucci G, Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA. 1989;86:6328–32.PubMedCrossRef Salvemini D, de Nucci G, Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA. 1989;86:6328–32.PubMedCrossRef
39.
Zurück zum Zitat Zatta A, Prosdocimi M, Bertele V, Bazzoni G, Del Maschio A. Inhibition of platelet function by polymorphonuclear leukocytes. J Lab Clin Med. 1990;116:651–60.PubMed Zatta A, Prosdocimi M, Bertele V, Bazzoni G, Del Maschio A. Inhibition of platelet function by polymorphonuclear leukocytes. J Lab Clin Med. 1990;116:651–60.PubMed
40.
Zurück zum Zitat Burton GW, Doba T, Gabe EJ, Hughes L, Lee FL, Prasad L, Ingold KU. Autoxidation of biological molecules. 4. Maximizing the antioxidant activity of phenols. J Am Chem Soc. 1985;107:7053–65.CrossRef Burton GW, Doba T, Gabe EJ, Hughes L, Lee FL, Prasad L, Ingold KU. Autoxidation of biological molecules. 4. Maximizing the antioxidant activity of phenols. J Am Chem Soc. 1985;107:7053–65.CrossRef
41.
42.
Zurück zum Zitat Barclay LRC. 1992 syntex award lecture model biomembranes: quantitative studies of peroxidation, antioxidant action, partitioning, and oxidative stress. Can J Chem. 1993;71:1–16.CrossRef Barclay LRC. 1992 syntex award lecture model biomembranes: quantitative studies of peroxidation, antioxidant action, partitioning, and oxidative stress. Can J Chem. 1993;71:1–16.CrossRef
43.
Zurück zum Zitat Mukai K, Ouchi A, Mitarai A, Ohara K, Matsuoka C. Formation and decay dynamics of vitamin E radical in the antioxidant reaction of vitamin E. Bull Chem Soc Jpn. 2009;82:494–503.CrossRef Mukai K, Ouchi A, Mitarai A, Ohara K, Matsuoka C. Formation and decay dynamics of vitamin E radical in the antioxidant reaction of vitamin E. Bull Chem Soc Jpn. 2009;82:494–503.CrossRef
44.
Zurück zum Zitat Liebler DC, Burr JA. Oxidation of vitamin E during iron-catalyzed lipid peroxidation: evidence for electron-transfer reactions of the tocopheroxyl radical. Biochemistry. 1992;31:8278–84.PubMedCrossRef Liebler DC, Burr JA. Oxidation of vitamin E during iron-catalyzed lipid peroxidation: evidence for electron-transfer reactions of the tocopheroxyl radical. Biochemistry. 1992;31:8278–84.PubMedCrossRef
45.
Zurück zum Zitat Ukeda H, Kawana D, Maeda S, Sawamura M. Spectrophotometric assay for superoxide dismutase based on the reduction of highly water-soluble tetrazolium salts by xanthine–xanthine oxidase. Biosci Biotechnol Biochem. 1999;63:485–8.CrossRef Ukeda H, Kawana D, Maeda S, Sawamura M. Spectrophotometric assay for superoxide dismutase based on the reduction of highly water-soluble tetrazolium salts by xanthine–xanthine oxidase. Biosci Biotechnol Biochem. 1999;63:485–8.CrossRef
46.
Zurück zum Zitat Navarrete M, Rangel C, Corchado JC, Espinosa-García J. Trapping of the OH radical by alpha-tocopherol: a theoretical study. J Phys Chem A. 2005;109:4777–84.PubMedCrossRef Navarrete M, Rangel C, Corchado JC, Espinosa-García J. Trapping of the OH radical by alpha-tocopherol: a theoretical study. J Phys Chem A. 2005;109:4777–84.PubMedCrossRef
47.
Zurück zum Zitat von Sonntag C. Advanced oxidation processes: mechanistic aspects. Water Sci Technol. 2008;58:1015–21.CrossRef von Sonntag C. Advanced oxidation processes: mechanistic aspects. Water Sci Technol. 2008;58:1015–21.CrossRef
48.
Zurück zum Zitat Floridi A, Piroddi M, Pilolli F, Matsumoto Y, Aritomi M, Galli F. Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater. 2009;5:2974–82.PubMedCrossRef Floridi A, Piroddi M, Pilolli F, Matsumoto Y, Aritomi M, Galli F. Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater. 2009;5:2974–82.PubMedCrossRef
49.
Zurück zum Zitat Arthur JF, Gardiner EE, Kenny D, Andrews RK, Berndt MC. Platelet receptor redox regulation. Platelets. 2008;19:1–8.PubMedCrossRef Arthur JF, Gardiner EE, Kenny D, Andrews RK, Berndt MC. Platelet receptor redox regulation. Platelets. 2008;19:1–8.PubMedCrossRef
50.
Zurück zum Zitat Del Principe D, Frega G, Savini I, Catani MV, Rossi A, Avigliano L. The plasma membrane redox system in human platelet functions and platelet–leukocyte interactions. Thromb Haemost. 2009;101:284–9.PubMed Del Principe D, Frega G, Savini I, Catani MV, Rossi A, Avigliano L. The plasma membrane redox system in human platelet functions and platelet–leukocyte interactions. Thromb Haemost. 2009;101:284–9.PubMed
51.
Zurück zum Zitat Itoh S, Susuki C, Tsuji T. Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species. J Biomed Mater Res A. 2006;77:294–303.PubMed Itoh S, Susuki C, Tsuji T. Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species. J Biomed Mater Res A. 2006;77:294–303.PubMed
Metadaten
Titel
Activation of platelets upon contact with a vitamin E-coated/non-coated surface
verfasst von
Hiroshi Tsukao
Kenichi Kokubo
Haruko Takahashi
Mina Nagasato
Takanori Endo
Naoto Iizuka
Toshihiro Shinbo
Minoru Hirose
Hirosuke Kobayashi
Publikationsdatum
01.06.2013
Verlag
Springer Japan
Erschienen in
Journal of Artificial Organs / Ausgabe 2/2013
Print ISSN: 1434-7229
Elektronische ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-013-0686-4

Weitere Artikel der Ausgabe 2/2013

Journal of Artificial Organs 2/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.